破裂性腹主动脉瘤腔内修复优于开放修复:VQI倾向匹配分析
基于VQI数据库2003-2018年4929例破裂性腹主动脉瘤修复病例,比较rEVAR与rOSR的短期和中期生存。倾向匹配后,rOSR的30天死亡率、主要不良事件和住院时间均显著高于rEVAR,1年生存率更低。
要点
- rOSR与rEVAR相比30天死亡率翻倍(OR 2.0,95%CI 1.6-2.7)。
- rOSR主要不良事件率68% vs rEVAR 35%。
- 解剖适合者应更积极采用腔内修复。
核心结论
- rEVAR在短期和中期生存上优于rOSR,且在匹配主要人口学、合并症和解剖变量后仍持续。
- rOSR存活者住院时间翻倍且并发症率更高。
研究设计与样本
- VQI数据库2003-2018年所有破裂性腹主动脉瘤修复病例的回顾性分析,共4929例(rEVAR 2749例,rOSR 2180例),并进行1:1倾向匹配。
主要发现
- 匹配前rOSR vs rEVAR:心肌缺血事件15% vs 10%(P < .001),主要不良事件67% vs 37%(P < .001),30天死亡34% vs 21%(P < .001)。
- 调整分析中rOSR预测30天死亡率OR 1.8(95%CI 1.5-2.2)。
- 匹配后724对:rOSR住院时间中位10天(IQR 5-19)vs rEVAR 5天(IQR 3-10),P < .001。
- 匹配后rOSR vs rEVAR:30天死亡32% vs 18%(P < .001),心肌梗死14% vs 8%(P = .002),呼吸并发症38% vs 20%(P < .001),急性肾损伤42% vs 26%(P < .001),主要不良事件68% vs 35%(P < .001)。
- 匹配后多变量回归rOSR的30天死亡率OR 2.0(95%CI 1.6-2.7);1年全因生存rEVAR 73% vs rOSR 59%(P < .001)。
临床怎么用
- 对解剖适合的破裂性腹主动脉瘤患者,应更积极采用腔内修复(rEVAR)以改善生存和减少并发症。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The few randomized trials comparing endovascular with open surgical repair of ruptured abdominal aortic aneurysm (rAAA) were poorly designed and heavily criticized. The short-term and midterm survival advantages of endovascular repair remain unclear. We sought to compare the two treatment modalities using a propensity-matched analysis in a real-world setting. METHODS: All ruptured cases of open surgical repair (rOSR) and endovascular aneurysm repair (rEVAR) in the Vascular Quality Initiative were analyzed (2003-2018). Raw and propensity-matched rEVAR and rOSR cohorts were compared. Primary and secondary outcomes included postoperative major adverse events (cardiovascular, pulmonary, renal, bowel or limb ischemia, reoperation) and 30-day and 1-year mortality. Univariate, multivariate, and Kaplan-Meier analyses were performed. RESULTS: There were 4929 rAAA repairs performed, 2749 rEVAR and 2180 rOSR. Compared with rEVAR patients, rOSR patients had higher rates of myocardial ischemic events (15% vs 10%; P < .001), major adverse events (67% vs 37%; P < .001), and 30-day death (34% vs 21%; P < .001). On adjusted analysis, rOSR was predictive of 30-day mortality (odds ratio, 1.8; 95% confidence interval, 1.5-2.2). After 1:1 matching, the study cohort consisted of 724 pairs of rOSR and rEVAR. The rOSR patients had twice the length of stay (median, 10 days [interquartile range, 5-19 days] vs 5 days [interquartile range, 3-10 days]; P < .001). Univariate analysis demonstrated persistent increased 30-day mortality after rOSR (32% vs 18%; P < .001) and higher rates of myocardial infarction (14% rOSR vs 8% rEVAR; P = .002), respiratory complications (38% vs 20%; P < .001), and acute kidney injury (42% vs 26%; P < .001). Overall major adverse event rate was higher after rOSR (68% vs 35%; P < .001). Multivariable regression analysis of the propensity-matched pairs demonstrated that rOSR was associated with double the 30-day mortality compared with rEVAR (odds ratio, 2.0; 95% confidence interval, 1.6-2.7). All-cause 1-year survival was 73% and 59% after rEVAR and rOSR in the propensity-matched cohort, respectively (P < .001). CONCLUSIONS: This is one of the largest studies of rAAA demonstrating clear short-term and midterm survival benefits of rEVAR over rOSR that persisted after matching on all major demographic, comorbid, and anatomic variables. Furthermore, patients who survived rOSR had twice the length of stay with increased rates of complications compared with rEVAR patients. These data suggest a more aggressive endovascular approach for rAAA in patients with suitable anatomy.
引用
- Wang LJ, Locham S, Al-Nouri O, et al. Endovascular repair of ruptured abdominal aortic aneurysm is superior to open repair: Propensity-matched analysis in the Vascular Quality Initiative. J Vasc Surg. 2020. PMID: 32273221. doi:10.1016/j.jvs.2019.11.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。